ORIC Pharmaceuticals, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 3 →InsidersNo open-market buys. 4 insiders sold $1.9M, 5 of 8 sales on a 10b5-1 plan.→HoldersNextech Invest 6.9%BlackRock 6.6%EcoR1 Capital 6.5%→Financing →PeersClosest companies: TNGX, WHWK, SEPN→
From the filings
Figures
- Net income
- −$140.4Mlast 12 months
- Operating cash flow
- −$110.9Mlast 12 months
- Cash and equivalents
- $37.5Mat the last balance sheet
- Shares outstanding
- 103.6M shareson issue